Long-time CBSA Member Aerotek to Change Name
By: Colorado BioScience Association Date: 07/13/2021
Aerotek, a leading talent solutions provider, today revealed that its three highly specialized business units—Industrial, Professional, and Engineering and Sciences—have separated into independen...
Learn MoreARCA Biopharma Provides Update On Aspen-COVID-19 Phase 2B Clinical Trial Evaluating RNAPC2 as a Potential Treatment for COVID-19
By: Colorado BioScience Association Date: 07/13/2021
CBSA Member ARCA Biopharama is receiving approvals from regulators in Argentina and Brazil to test your possible COVID-19 treatment. Find out more in the press release.
Learn MoreVitriVax Announces Series A Financing to Further Demonstrate Feasibility of its Thermostable, Single-Dose Vaccine Technology, Aiming to Make Life-Saving Biologics Widely Accessible to Underserved Populations Globally
By: Colorado BioScience Association Date: 07/08/2021
VitriVax, developer of a novel stabilization and delivery platform for vaccines and therapeutics, today announced it has closed its first institutional financing round with Adjuvant Capital. Series A...
Learn MoreDOD, HHS Awards a $35.1M contract to LightDeck Diagnostics to increase production of its 5-Minute point-of-care tests for COVID-19
By: Colorado BioScience Association Date: 07/08/2021
On July 8, 2021, the Department of Defense (DOD), on behalf of and in coordination with the Department of Health and Human Services (HHS), awarded a $35.1 million contract to LightDeck Diagnostic...
Learn MorePharmaJet partner Zydus Cadila seeks EUA on world’s first plasmid DNA COVID-19 vaccine
By: Colorado BioScience Association Date: 07/07/2021
PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila has applied for Emergency Use Authorization (EUA) to the office of the Drug Control...
Learn MoreAGC Biologics Enters Agreement to Acquire Facility in Longmont, CO, Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities and Offerings
By: Colorado BioScience Association Date: 07/02/2021
AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the signing of a purchase agreement for a state-of-the-art Cell and Gene Therapy...
Learn MoreVaporox Closes on a $4M Series A Fund Raising Round Led by Bioventus
By: Colorado BioScience Association Date: 06/29/2021
Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed a minority investment in Vaporox, Inc., a developer of a highly innovative...
Learn MoreAt-home fertility test kit maker Proov expands to EU after landing CE clearance
By: Colorado BioScience Association Date: 06/25/2021
At-home fertility test maker Proov is expanding its footprint to Europe after receiving CE marking for its ovulation-confirming test kit. Proov’s ovulation testing kit got clearance by the F...
Learn MoreBrickell Biotech Announces Initiation of a Phase 1 Study of Sofpironium Bromide Gel in Primary Palmoplantar Hyperhidrosis Patients by its Development Partner, Kaken Pharmaceutical in Japan
By: Colorado BioScience Association Date: 06/24/2021
Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatm...
Learn MoreInside Medtronic's plans for its new 400,000-square-foot Lafayette campus
By: Colorado BioScience Association Date: 06/24/2021
The company is preparing to break ground on its new campus, which will prioritize collaboration and innovation. Find out more in the Denver Business Journal article.
Learn More